Glycosidase inhibitors and methods of synthesizing same
OwnerBrian M. Pinto, Blair D. Johnston +1inventors
InventorsBrian M. Pinto, Blair D. Johnston, Ahmad Ghavami
Life of this patent
Estimating the term…
Loading patent…
OwnerBrian M. Pinto, Blair D. Johnston +1inventors
InventorsBrian M. Pinto, Blair D. Johnston, Ahmad Ghavami
Estimating the term…
A method for synthesizing Salacinol, its stereoisomers, and non-naturally occurring selenium and nitrogen analogues thereof having the general formula (I): 1 The compounds are potentially useful as glycosidase inhibitors. The synthetic schemes comprise reacting a cyclic sulfate with a 5-membered ring sugar containing a heteroatom (X). The heteroatom preferably comprises sulfur, selenium, or nitrogen. The cyclic sulfate and ring sugar reagents may be readily prepared from carbohydrate precursors, such as D-glucose, L-glucose, D-xylose and L-xylose. The target compounds are prepared by opening of the cyclic sulfates by nucleophilic attack of the heteroatoms on the 5-membered ring sugars. The resulting heterocyclic compounds have a stable, inner salt structure comprising a heteroatom cation and a sulfate anion. The synthetic schemes yield various stereoisomers of the target compounds in moderate to good yields with limited side-reactions. In an alternative embodiment of the invention, the cyclic sulfate may be similarly reacted with a 6-membered ring sugar containing a heteroatom (X) to yield a compound having the general formula (XII): 2
A non-naturally occurring compound selected from the group consisting of compounds represented by the general formula (I) and stereoisomers and pharmaceutically acceptable salts thereof:
A process for the production of a compound having the formula (VI) comprising reacting a cyclic sulfate selected from the group consisting of compounds having the formulas (VII) and (VIII) with a sugar compound having the formula (IX) where R═H, COR, CH2C6H5, CH2C6H4—OMep.
A compound selected from the group consisting of compounds represented by the general formula (XII) and stereoisomers and pharmaceutically acceptable salts thereof:
Dependencies are inferred from the claim text.